Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001599298-22-000069
Filing Date
2022-07-06
Accepted
2022-07-07 10:26:12
Documents
5
Period of Report
2022-07-06

Document Format Files

Seq Description Document Type Size
1 DEF 14A summit-specialmeetingdefpr.htm DEF 14A 274957
2 screenshot2022-06x24164948.jpg GRAPHIC 128736
3 screenshot2022-06x24165436.jpg GRAPHIC 126546
4 screenshot2022-07x06092614.jpg GRAPHIC 167138
5 screenshot2022-07x06164537.jpg GRAPHIC 21674
  Complete submission text file 0001599298-22-000069.txt   888316
Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36866 | Film No.: 221070854
SIC: 2834 Pharmaceutical Preparations